Name
Arcus Biosciences
Company Description
Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing first- or best-in-class medicines against well-characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. The company has expedited the development of multiple investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73, dual A2a/A2b receptor and CD39), AXL and HIF-2a. For more information visit www.arcusbio.com.
Website
Product Categories (5)
Genitourinary Cancer, Lung Cancer, Clinical Trials, Drug Development, Immunotherapy
Conquer Cancer, the ASCO Foundation Donor
Yes
Phone (If provided, phone will display online and in-print)
510-694-6200
Address
Hayward, CA
United States
United States
Recognition
